PubMed

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.

Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP.

Diabetes. 2002 Sep;51(9):2796-803.PMID: 12196473 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.

Berkowitz K, Peters R, Kjos SL, Goico J, Marroquin A, Dunn ME, Xiang A, Azen S, Buchanan TA.

Diabetes. 1996 Nov;45(11):1572-9.PMID: 8866563 [PubMed - indexed for MEDLINE]Related articles

Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.

Buchanan TA, Xiang AH, Peters RK, Kjos SL, Berkowitz K, Marroquin A, Goico J, Ochoa C, Azen SP.

Diabetes. 2000 May;49(5):782-8.PMID: 10905487 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function.

Xiang AH, Peters RK, Kjos SL, Goico J, Ochoa C, Marroquin A, Tan S, Hodis HN, Azen SP, Buchanan TA.

J Clin Endocrinol Metab. 2004 Jun;89(6):2846-51.PMID: 15181067 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes.

Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Kawakubo M, Buchanan TA.

Diabetes. 2006 Feb;55(2):517-22.PMID: 16443789 [PubMed - indexed for MEDLINE]Related articlesFree article

Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes.

Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA.

Diabetes. 2006 Apr;55(4):1074-9.PMID: 16567531 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study.

Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K.

Metabolism. 2003 Sep;52(9):1211-7.PMID: 14506629 [PubMed - indexed for MEDLINE]Related articles

TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

Azen SP, Peters RK, Berkowitz K, Kjos S, Xiang A, Buchanan TA.

Control Clin Trials. 1998 Apr;19(2):217-31.PMID: 9551285 [PubMed - indexed for MEDLINE]Related articles

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

[No authors listed]

Diabetes Care. 1999 Apr;22(4):623-34. Erratum in: Diabetes Care 1999 Aug;22(8):1389. PMID: 10189543 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus.

Peters RK, Kjos SL, Xiang A, Buchanan TA.

Lancet. 1996 Jan 27;347(8996):227-30.PMID: 8551882 [PubMed - indexed for MEDLINE]Related articles

Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.

Prigeon RL, Kahn SE, Porte D Jr.

J Clin Endocrinol Metab. 1998 Mar;83(3):819-23.PMID: 9506734 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study.

Snitker S, Watanabe RM, Ani I, Xiang AH, Marroquin A, Ochoa C, Goico J, Shuldiner AR, Buchanan TA; Troglitazone in Prevention of Diabetes (TRIPOD) study.

Diabetes Care. 2004 Jun;27(6):1365-8.PMID: 15161789 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.

Osei K, Rhinesmith S, Gaillard T, Schuster D.

Metabolism. 2003 May;52(5):565-72.PMID: 12759885 [PubMed - indexed for MEDLINE]Related articles

Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes.

Xiang AH, Peters RK, Kjos SL, Ochoa C, Marroquin A, Goico J, Tan S, Wang C, Azen SP, Liu CR, Liu CH, Hodis HN, Buchanan TA.

J Clin Endocrinol Metab. 2005 Apr;90(4):1986-91. Epub 2004 Dec 28.PMID: 15623809 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.

Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H.

J Cardiol. 2003 Apr;41(4):183-90.PMID: 12728539 [PubMed - indexed for MEDLINE]Related articles

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J.

N Engl J Med. 1994 Nov 3;331(18):1188-93.PMID: 7935656 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.

Metabolism. 2003 Feb;52(2):173-80.PMID: 12601628 [PubMed - indexed for MEDLINE]Related articles

Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.

Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS.

J Clin Invest. 1997 Aug 1;100(3):530-7.PMID: 9239399 [PubMed - indexed for MEDLINE]Related articlesFree article

Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.

Osei K, Rhinesmith S, Gaillard T, Schuster D.

Metabolism. 2004 Apr;53(4):414-22.PMID: 15045685 [PubMed - indexed for MEDLINE]Related articles

Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.

Willi SM, Kennedy A, Brant BP, Wallace P, Rogers NL, Garvey WT.

Diabetes Res Clin Pract. 2002 Nov;58(2):87-96.PMID: 12213349 [PubMed - indexed for MEDLINE]Related articles